Methylenetetrahydrofolate dehydrogenase (MTHFD) enzyme polymorphism as a maternal risk factor for trisomy 21: a clinical study
2010

MTHFD Enzyme Polymorphism and Down Syndrome Risk

Sample size: 72 publication Evidence: low

Author Information

Author(s): Neagos D, Cretu R, Tutulan–Cunita A, Stoian V, Bohiltea LC

Primary Institution: Carol Davila University of Medicine and Pharmacy

Hypothesis

Is the MTHFD1 1958G>A polymorphism a maternal risk factor for Down syndrome?

Conclusion

The study found no significant association between MTHFD1 polymorphism and Down syndrome pregnancies.

Supporting Evidence

  • The study included a total of 72 women, with 26 having Down syndrome babies and 46 being controls.
  • Genetic analysis showed no significant differences in MTHFD1 allele frequencies between the two groups.
  • The findings contrast with previous studies that suggested a link between MTHFD1 polymorphism and Down syndrome.

Takeaway

The study looked at whether a specific gene change in mothers affects the chance of having a baby with Down syndrome, but it found no link.

Methodology

The study included 26 mothers of Down syndrome babies and 46 control mothers, using questionnaires and genetic analysis to assess MTHFD1 polymorphism.

Limitations

The study's findings may not be generalizable beyond the Romanian urban-area cohort.

Participant Demographics

Participants were Romanian women, with case mothers being younger than 40 years old.

Statistical Information

P-Value

0.63

Confidence Interval

0.54–5.26

Statistical Significance

p=0.63

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication